CLINICAL_TRIALS
research
· 2026-02-25
Clinical Trial Update: Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease [Phase 3]
Summary
Phase 3 trial evaluating outcomes after stopping hydroxychloroquine in elderly patients with systemic lupus erythematosus; currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NYU Langone Health | Conditions: Systemic Lupus Erythematosus | Phase 3 | Status: RECRUITING